XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Three Months Ended May 31, 2021 (Tables)
3 Months Ended
May 31, 2022
Condensed Financial Information Disclosure [Abstract]  
Schedule of the company’s previously issued balance
   As of May 31, 2021 
   As Previously
Reported
   Adjustments   Reclassifications   As Restated   Notes 
Accrued expenses (including accrued interest)  $1,529,273   $(92,625)  $5,125   $1,441,772    [D][1] 
Note payable   246,360    
-
    (5,125)   241,235    [1]
Derivative warrant liability   
-
    1,238,955    
-
    1,238,955    [A] 
Common stock   7,297    
-
    (2)   7,295      
Additional paid-in capital   446,555,737    (136,004)   2    446,695,305    [B] 
         258,636    
-
         [C] 
         16,934              [C] 
Accumulated deficit  $(466,992,328)  $(1,238,955)  $
-
   $(468,278,223)   [A] 
         136,004    
-
         [B] 
         (258,636)   
-
         [C] 
         (16,934)   
-
         [C] 
         92,626    
-
         [D] 

 

Schedule of the company’s previously issued statement of operations
   As of May 31, 2021 
   As Previously
Reported
   Adjustments   Reclassifications   As Restated   Notes 
Selling, general and administrative expense  $812,681   $16,934   $
           -
   $736,989    [C]
         (92,626)   
-
         [D] 
Gain on extinguishment of derivative warrant liability   
-
    44,620    
-
    44,620    [A] 
Change in fair value of derivative warrant liability   
-
    82,800    
-
    82,800    [A] 
Net loss  $(1,108,829)  $203,112   $
-
   $(905,717)     
                          
Net loss per share, basic and diluted  $(0.02)            $(0.01)     

 

Schedule of the company’s previously issued statement of shareholder deficit
   Common Stock
Shares
   Common
Stock Amount
   Additional
Paid-In
Capital
   Accumulated
Deficit
   Total
Shareholders’
Deficit
 
Balance, February 28, 2021, as previously reported   71,107,442   $7,109   $446,126,640   $(465,883,499)  $(19,749,750)
Prior period revisions   
-
    
-
    122,632    (1,489,007)   (1,366,375)
Corrections of errors   (4,433)                  
-
 
Balance, February 28, 2021, as restated   71,103,009   $7,109   $446,249,272   $(467,372,506)  $(21,116,125)
                          
Balance, May 31, 2021, as previously reported   72,972,775   $7,297   $446,555,737   $(466,992,328)  $(20,429,294)
Prior period revisions   
-
    (2)   122,634    (1,489,007)   (1,366,375)
Share-based compensation addition   -    
-
    16,934    
-
    16,934 
Net loss reduction   -    
-
    
-
    203,112    203,112 
Corrections of errors   (4,433)   
-
    
-
    
-
    
-
 
Balance, May 31, 2021, as restated   71,103,009   $7,295   $446,695,305   $(468,278,223)  $(21,575,623)

 

Schedule of the company’s previously issued statement of cash flows
    As of May 31, 2021  
    As Previously
Reported
    Adjustments     Reclassifications     As Restated     Notes  
Cash flows from operating activities:                              
Net loss   $ (1,108,829 )   $ 203,112     $
-
    $ (905,717 )     [A] [C] [D]  
Gain on extinguishment of derivative warrant liability    
-
      (44,620 )    
-
      (44,620 )     [A]  
Change in fair value of derivative warrant liability    
-
      (82,800 )    
-
      (82,800 )     [A]  
Share-based compensation expense     146,284       16,934      
-
      163,218       [C]  
Changes in working capital assets and liabilities:                                        
Operating lease right-to-use asset    
-
     
-
      40,383       40,383          
Accounts payable and accrued expenses     199,562       (92,626 )     1,457       108,392         [1]
Accrued interest on notes payable     270,274      
-
      (1,457 )     268,817         [1]
Operating lease liability     47,532      
-
      (40,383 )     7,149